| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3923335 | European Urology | 2007 | 8 Pages |
Abstract
The combination of docetaxel, vinorelbine, and zoledronic acid is associated with improvement in biochemical, objective, and pain responses and is well tolerated as a first-line treatment for HRPC.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Giuseppe Di Lorenzo, Riccardo Autorino, Sisto Perdonà , Michele De Laurentiis, Massimo D'Armiento, Giuseppe Cancello, Vincenzo Mirone, Ciro Imbimbo, Nicola Longo, Vincenzo Altieri, Gianpaolo Tortora, William D. Figg, Sabino De Placido,